AXL and non-small cell lung carcinoma: Activation of epidermal growth factor receptor (EGFR) pathways and MEK/ERK signalling lead to c-Jun mediated Axl mRNA expression in non-small cell lung cancer (NSCLC) and head and neck squamous cell carcinoma (HNSCC) [19].